Cargando…

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists

Drugs formulated from monoclonal antibodies (mAbs) are clinically effective in various diseases. Repeated administration of mAbs, however, elicits an immune response in the form of anti-drug-antibodies (ADA), thereby reducing the drug's efficacy. Notwithstanding their importance, the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaisman-Mentesh, Anna, Rosenstein, Shai, Yavzori, Miri, Dror, Yael, Fudim, Ella, Ungar, Bella, Kopylov, Uri, Picard, Orit, Kigel, Aya, Ben-Horin, Shomron, Benhar, Itai, Wine, Yariv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930160/ https://www.ncbi.nlm.nih.gov/pubmed/31921180 http://dx.doi.org/10.3389/fimmu.2019.02921

Ejemplares similares

Acute Chest Pain as an Infusion Reaction to Vedolizumab
por: Levartovsky, Asaf, et al.
Publicado: (2022)

PASA: Proteomic analysis of serum antibodies web server
por: Avram, Oren, et al.
Publicado: (2021)

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
por: Levartovsky, Asaf, et al.
Publicado: (2023)

Distal Fecal Wash Host Transcriptomics Identifies Inflammation Throughout the Colon and Terminal Ileum
por: Dan, Stav, et al.
Publicado: (2023)

Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months
por: Eyran, Tsuf, et al.
Publicado: (2022)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening
por: Ben-Shatach, Zohar, et al.
Publicado: (2022)

ASAP - A Webserver for Immunoglobulin-Sequencing Analysis Pipeline
por: Avram, Oren, et al.
Publicado: (2018)

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis
por: Yablecovitch, Doron, et al.
Publicado: (2019)

Immune function in newborns with in-utero exposure to anti-TNFα therapy
por: Weiss, Batia, et al.
Publicado: (2022)

Incidentally Diagnosed Asymptomatic Crohn’s Disease: A Retrospective Cohort Study of Long-Term Clinical Outcomes
por: Grinman, Ana, et al.
Publicado: (2022)

Outcome of inflammatory bowel disease patients with prior malignancy
por: Shani, Uria, et al.
Publicado: (2023)

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
por: Vaisman-Mentesh, Anna, et al.
Publicado: (2020)

Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?
por: Levartovsky, Asaf, et al.
Publicado: (2020)

Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection
por: Ukashi, Offir, et al.
Publicado: (2022)

BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women
por: Rosenberg-Friedman, Michal, et al.
Publicado: (2021)

Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
por: Yablecovitch, Doron, et al.
Publicado: (2022)

Predictors of mortality in inflammatory bowel disease patients treated for pneumonia
por: Ukashi, Offir, et al.
Publicado: (2020)

Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
por: Levartovsky, Asaf, et al.
Publicado: (2021)

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
por: Veisman, Ido, et al.
Publicado: (2021)

Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
por: Mahajna, Hussein, et al.
Publicado: (2020)

Signs and Symptoms of Acute Bowel Inflammation and the Risk of Progression to Inflammatory Bowel Disease: A Retrospective Analysis
por: Levartovsky, Asaf, et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
por: Ben-Horin, Shomron, et al.
Publicado: (2022)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome
por: Laish, Ido, et al.
Publicado: (2022)

Magnetic resonance enterography in pregnant women with Crohn’s disease: case series and literature review
por: Stern, Myriam D, et al.
Publicado: (2014)

Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence
por: Ukashi, Offir, et al.
Publicado: (2023)

Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics
por: Soffer, Shelly, et al.
Publicado: (2020)

Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform
por: Engel, Tal, et al.
Publicado: (2023)

Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across Tissues
por: Aizik, Ligal, et al.
Publicado: (2021)

Familial ulcerative colitis in Israeli Jews: its prevalence and clinical severity compared to sporadic disease
por: Ben-Horin, Shomron, et al.
Publicado: (2011)

The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?
por: Yablecovitch, Doron, et al.
Publicado: (2018)

Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease
por: Ukashi, Offir, et al.
Publicado: (2023)

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
por: Carter, Dan, et al.
Publicado: (2018)

Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel
por: Avinir, Asia, et al.
Publicado: (2022)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease
por: Lahat, Adi, et al.
Publicado: (2017)

Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals
por: Ukashi, Offir, et al.
Publicado: (2022)

Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study
por: Kopylov, Uri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kjoq0dejtdhsr4bg65gm2rdfrl